Showing results (91-100 of 148) with videos related to
Sort By:
Pageof 15
Alimentary Pharmacology & Therapeutics|October 24, 2008
Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind studyP M Hellström, J Hein, P Bytzer, et al.European Journal of Nuclear Medicine|July 20, 2000
Nationwide standardisation and evaluation of scintigraphic gastric emptying: reference values and comparisons between subgroups in a multicentre trialP Grybäck, G Hermansson, E Lyrenäs, et al.Scandinavian Journal of Gastroenterology|October 11, 2002
Pyoderma gangrenosum associated with crohn disease: effect of TNF-alpha blockade with infliximabT Ljung, M Staun, O Grove, et al.Scandinavian Journal of Gastroenterology|January 1, 1993
Pancreaticobiliary juice releases motilin during phase I of the migrating motor complex in manI Nilsson, T Svenberg, P M Hellström, et al.Journal of Internal Medicine|July 17, 2001
Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetesM K Gutniak, J Svartberg, P M Hellström, et al.Acta Physiologica Scandinavica|May 1, 1990
Relationship between interdigestive gallbladder emptying, plasma motilin and migrating motor complex in manB I Nilsson, T Svenberg, T Tollström, et al.Neurogastroenterology and Motility|March 27, 2013
Intravenous ghrelin accelerates postoperative gastric emptying and time to first bowel movement in humansY Falkén, D-L Webb, M Abraham-Nordling, et al.Scandinavian Journal of Gastroenterology|October 9, 2001
Rectal nitric oxide assessment in children with Crohn disease and ulcerative colitis. Indicator of ileocaecal and colorectal affectionT Ljung, M Herulf, E Beijer, et al.Acta Physiologica (Oxford, England)|September 27, 2012
Effective treatment of mouse experimental colitis by alpha 2 integrin antibody: comparison with alpha 4 antibody and conventional therapyL Gillberg, S Berg, P J de Verdier, et al.The American Journal of Physiology|September 14, 1999
GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humansE Näslund, J Bogefors, S Skogar, et al.Pageof 15